RU486 has been shown to induce phosphorylation at Ser226 (transcriptional repression), but not Ser211 (transcriptional activation). With GR antagonist and CDK5 inhibitor, reduction in BDNF and cognitive dysfunction in aged mice were both rescued. This evidence concerns the gene NR3C1 and cognition.